Company Filing History:
Years Active: 2023
Title: Bakary-Barry Touré: Innovator in FGFR Inhibitors
Introduction
Bakary-Barry Touré is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His innovative work has the potential to impact the treatment of various disorders associated with FGFR signaling.
Latest Patents
Touré holds a patent for "FGFR inhibitors and methods of use thereof." This patent relates to novel compounds and pharmaceutical compositions designed to inhibit the activity of FGFR enzymes. The methods outlined in the patent aim to treat disorders linked to FGFR signaling, showcasing the therapeutic potential of his discoveries. He has 1 patent to his name.
Career Highlights
Throughout his career, Touré has worked with notable companies in the biotechnology sector. He has been associated with Relay Therapeutics, Inc. and D.E. Shaw Research, LLC, where he has contributed to groundbreaking research and development efforts.
Collaborations
Touré has collaborated with esteemed colleagues, including Heike Schoenherr and Fabrizio Giordanetto. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Bakary-Barry Touré is a distinguished inventor whose work on FGFR inhibitors holds promise for advancing medical treatments. His contributions to the pharmaceutical industry reflect his commitment to innovation and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.